C-66

N/A

Report date: 2023/01/12 10:45:13
NME

Base Information

Drug NameC-66
Drug Alias NameC-66
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-Jun N-terminal kinase inhibitors
Targetsc-Jun N-terminal kinase 1c-Jun N-terminal kinase
Therapy Area/IndicationsDiabetic CardiomyopathiesDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWenzhou Medical University
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesWenzhou Medical University
Inactive CompaniesN/A
Active IndicationsDiabetic CardiomyopathiesDiabetic Nephropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A